Coronary CTA: Non-invasive, low cost alternative for 'intermediate risk' patients

December 1, 2008

Coronary CTA offers a low cost, non-invasive alternative to conventional angiography for evaluating patients who are suspected of having coronary artery disease; true even if the patients have calcified coronary artery plaques, according to a study performed at the Thomas Jefferson University Hospital, Philadelphia, PA.

The study included 31 patients who had one or more calcified coronary artery plaques that were discovered during coronary CTA. Calcified plaques in the arteries were graded as small, moderate or large. Initially the accuracy rate of determining the degree of stenosis caused by the larger calcified plaques was 67%. The study is ongoing and "now with further experience, the accuracy rate of determining the degree of stenosis with larger plaques is 72%," said David C. Levin, MD, lead author of the study.

"Patients who have calcified plaques in their coronary arteries can be evaluated accurately using coronary CTA. The procedure is non-invasive, cheaper and does not require hospitalization. Using coronary CTA you can look at a patient's arteries from an infinite number of angles and look at cross sections of vessels. With conventional angiography, the patient usually is admitted to the hospital and the arteries are only visible from 7 to 10 different angles," said Dr. Levin.

Coronary CTA is recommended for patients with an intermediate risk of coronary artery disease. "A good candidate is somebody who has an atypical chest pain pattern; chest pain that comes and goes during the day, night, exercise, rest etc. Family history, high cholesterol, diabetes, smoking and hypertension also play a big factor in the determining risk category," said Dr. Levin.

Source: American Roentgen Ray Society


print this article email this article download pdf blog this article bookmark this article     Stumble it Digg this share on Facebook retweet share on Reddit add to delicious
Rate this story - 5 /5 (1 vote)


December 1, 2008 all stories

Comments: 0

5 /5 (1 vote)
  • Stumble this up

  • Digg this

  • share this

  • hide
  • Related Stories




  • hide
  • Relevant PhysicsForums posts

Other News

Why can't chimps speak? Study links evolution of single gene to human capacity for language

Why can't chimps speak? Study links evolution of single gene to human capacity for language

Medicine & Health / Genetics

created 41 minutes ago | popularity not rated yet | comments 0

(PhysOrg.com) -- If humans are genetically related to chimps, why did our brains develop the innate ability for language and speech while theirs did not?


New brain findings on dyslexic children

Medicine & Health / Neuroscience

created 57 minutes ago | popularity not rated yet | comments 0

The vast majority of school-aged children can focus on the voice of a teacher amid the cacophony of the typical classroom thanks to a brain that automatically focuses on relevant, predictable and repeating auditory information, ...


Athletes on performance enhancers more likely to abuse alcohol, other drugs

Medicine & Health / Health

created 57 minutes ago | popularity not rated yet | comments 0

College athletes who use performance-enhancing substances may be at heightened risk of misusing alcohol and using recreational drugs as well, according to new research in the Journal of Studies on Alcohol and Drugs.


Novel mouse gene reduces major pathologies associated with Alzheimer's disease

Medicine & Health / Neuroscience

created 1hour ago | popularity not rated yet | comments 0

A new study reveals that a previously undiscovered mouse gene reduces the two major pathological perturbations commonly associated with Alzheimer's disease (AD). The research, published by Cell Press in the November 12 issue ...


Drug industry presses FDA to allow more online ads (AP)

Drug industry presses FDA to allow more online ads

Medicine & Health / Medications

created 1hour ago | popularity not rated yet | comments 0

(AP) -- As federal regulators take their first tentative steps toward policing the wild west of medical information online, pharmaceutical companies are pressing their case to market drugs via Google, Twitter ...